Gene · 5603
Papers1,919
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,919
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Search for Potential VDR/Partner Composite Elements in Regulatory DNA of Genes Associated with Respiratory Infections and Atopic Diseases. | Int J Mol Sci | 2025 | 41516283 | PubTator, text mining | PubMed |
| Differentially expressed mRNAs of neural signaling pathway genes in peripheral blood leukocytes as biomarkers for schizophrenia. | Schizophrenia (Heidelb) | 2025 | 41330925 | PubTator, text mining | PubMed |
| Extracellular vesicles in monitoring and modulation of oocyte competence: focus on exosomes. | J Ovarian Res | 2025 | 41272847 | PubTator, text mining | PubMed |
| MAPK13 promotes the progression of papillary thyroid cancer. | Eur Thyroid J | 2025 | 41263302 | PubTator, text mining | PubMed |
| Proteomic analysis of Burkitt lymphoma tissues: insights into the impact of age and EBV infection on protein expression and molecular characteristics. | Discov Oncol | 2025 | 41258592 | PubTator, text mining | PubMed |
| Investigating the Roles of MAPKs as Precision Oncology Targets: A Multi-cancer Expression and Survival Study. | Cancer Genomics Proteomics | 2025 | 41151853 | PubTator, text mining | PubMed |
| Multidimensional transcriptomic and immune profiling of papillary thyroid cancer: bridging molecular networks, disease stage, survival outcomes, and drug discovery. | Discov Oncol | 2025 | 41021127 | PubTator, text mining | PubMed |
| Somatostatin Receptor 2 Overexpression in Hepatocellular Carcinoma: Implications for Cancer Biology and Therapeutic Applications. | Curr Oncol | 2025 | 41002582 | PubTator, text mining | PubMed |
| Withdrawal: Methylosome protein 50 and PKCδ/p38δ protein signaling control keratinocyte proliferation via opposing effects on p21Cip1 gene expression. | J Biol Chem | 2025 | 40946420 | PubTator, text mining | PubMed |
| Correction: Protein arginine methyltransferase 5 (PRMT5) signaling suppresses protein kinase Cδ- and p38δ-dependent signaling and keratinocyte differentiation. | J Biol Chem | 2025 | 40946418 | PubTator, text mining | PubMed |
| Withdrawal: p38δ regulates p53 to control p21Cip1 expression in human epidermal keratinocytes. | J Biol Chem | 2025 | 40946417 | PubTator, text mining | PubMed |
| Withdrawal: A regulatory role for p38δ MAPK in keratinocyte differentiation: Evidence for p38δ-ERK1/2 complex formation. | J Biol Chem | 2025 | 40946416 | PubTator, text mining | PubMed |
| CRISPR/Cas9 in colorectal cancer: Revolutionizing precision oncology through genome editing and targeted therapeutics. | Iran J Basic Med Sci | 2025 | 40896696 | PubTator, text mining | PubMed |
| Desmoglein-driven dynamic signaling in pemphigus vulgaris: a systematic review of pathogenic pathways. | NPJ Regen Med | 2025 | 40846710 | PubTator, text mining | PubMed |
| Single cell spatial transcriptomics links Wnt signaling disruption to extracellular matrix development in a cleft palate model. | Sci Rep | 2025 | 40804270 | PubTator, text mining | PubMed |
| HEP14 treatment improves ovarian function in aged mice through mitophagy enhancement and oxidative stress reduction. | Commun Biol | 2025 | 40751000 | PubTator, text mining | PubMed |
| Characterization of novel anoikis-related genes as prognostic biomarkers and key determinants of the immune microenvironment in esophageal cancer. | Front Immunol | 2025 | 40746552 | PubTator, text mining | PubMed |
| Integrating Bulk RNA and Single-Cell Sequencing Data Reveals Genes Related to Energy Metabolism and Efferocytosis in Lumbar Disc Herniation. | Biomedicines | 2025 | 40722613 | PubTator, text mining | PubMed |
| Molecular Study from the Signaling Pathways of Four Potential asthma triggers: AKT1, MAPK13, STAT1, and TLR4. | Int J Mol Sci | 2025 | 40650018 | PubTator, text mining | PubMed |
| PANoptosis-driven molecular stratification in esophageal squamous cell carcinoma: A multi-omics prognostic model and FGFR-Targeted therapeutic validation. | Comput Biol Med | 2025 | 40628169 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5603/papers?page=3